Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SHE/301281 stock hub

SHE/301281 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301281is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.4B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301281

In the news

Latest news · SHE/301281

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E189.6

P25 23.5P50 41.3P75 83.2

ROE1.7

P25 -0.9P50 4.1P75 8.8

ROIC2.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301281 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

CNY

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	696
Employees Change	72%
Employees Change Percent	11.54
Enterprise value	CNY 4.2B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	CNE1000061V8
Last refreshed	2026-05-10
Market cap	CNY 4.4B
Price	CNY 40.44
Price currency	CNY
Rev Per Employee	644,146.61x
Sector	Healthcare
Sic	2834
Symbol	she/301281
Website	https://www.keyuanpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.54%
EV Earnings	177.27x
EV/EBIT	66.21x
EV/EBITDA	35.62x
EV/FCF	-78.52x
EV/Sales	9.31x
FCF yield	-1.21%
P/B ratio	3.14x
P/E ratio	189.57x
P/S ratio	9.77x
PE Ratio3 Y	71.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.02%
EBITDA Margin	18.7%
Gross margin	51.79%
Gross Profit	CNY 232.2M
Gross Profit Growth	20.09%
Gross Profit Growth Q	62.83%
Gross Profit Growth3 Y	5.34%
Gross Profit Growth5 Y	19.15%
Net Income	CNY 23.5M
Net Income Growth	-62.04%
Net Income Growth Q	30.27%
Net Income Growth3 Y	-37.39%
Net Income Growth5 Y	3.41%
Pretax Margin	5.76%
Profit Margin	5.25%
Profit Per Employee	CNY 33,824
ROA	1.34
Roa5y	5.03
ROCE	2.32
ROE	1.72
Roe5y	10.69
ROIC	2.89
Roic5y	12.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	32.35%
Cagr3y	16.01%
EPS Growth	-62.87
EPS Growth Q	30.25
EPS Growth3 Y	-43.44
EPS Growth5 Y	-2.56
OCF Growth3 Y	-13.72%
Revenue Growth	4.59x
Revenue Growth Q	45.05x
Revenue Growth3 Y	-0.39x
Revenue Growth5 Y	10.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.27
Assets	CNY 1.8B
Cash	CNY 363.6M
Current Assets	CNY 731.6M
Current Liabilities	CNY 239.7M
Debt	CNY 156.6M
Debt EBITDA	CNY 1.87
Debt Equity	CNY 0.11
Debt FCF	CNY -2.95
Equity	CNY 1.4B
Interest Coverage	2,170.6
Liabilities	CNY 397.4M
Long Term Assets	CNY 1.1B
Long Term Liabilities	CNY 157.7M
Net Cash	CNY 207M
Net Cash By Market Cap	CNY 4.73
Net Cash Growth	-37.45%
Net Debt EBITDA	CNY -2.47
Net Debt Equity	CNY -0.15
Tangible Book Value	CNY 1.3B
Tangible Book Value Per Share	CNY 11.8
WACC	3.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.05
Inventory Turnover	1.52
Net Working Capital	CNY 167.7M
Quick ratio	2.4
Working Capital	CNY 491.9M
Working Capital Turnover	CNY 0.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.23%
Dividend Growth	-33.33%
Dividend Growth Years	0%
Dividend per share	CNY 0.05
Dividend Years	3
Dividend Yield	0.12%
Ex Div Date	2025-05-20
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	110.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	32.32%
200-day SMA	34.79
3Y total return	56.13%
50-day SMA	41.2
50-day SMA vs 200-day SMA	50over200
All Time High	63.99
All Time High Change	-36.8%
All Time High Date	2023-08-14
All Time Low	18.52
All Time Low Change	118.36%
All Time Low Date	2024-09-18
ATR	2.23
Beta	-0.06
Beta1y	1.09
Beta2y	0.51
Ch YTD	38.02
High	41.14
High52	53.99
High52 Date	2026-03-20
High52ch	-25.1%
Low	39.6
Low52	25.87
Low52 Date	2025-12-17
Low52ch	56.32%
Ma50ch	-1.84%
Price vs 200-day SMA	16.25%
RSI	55.37
RSI Monthly	56.2
RSI Weekly	56.16
Sharpe ratio	0.71x
Sortino ratio	1.2
Total Return	-2.11%
Tr YTD	38.02
Tr1m	15.05%
Tr1w	2.82%
Tr3m	20.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 36M
Operating Income Growth	-2.72
Operating Income Growth Q	100.8
Operating Income Growth3 Y	-27.12
Operating Income Growth5 Y	6.86
Operating margin	8.02

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,341,600%
Net Borrowing	89,956,554
Shares Insiders	4.88%
Shares Institutions	10.17%
Shares Out	108,290,000
Shares Qo Q	-7.06%
Shares Yo Y	2.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -53.1M
Average Volume	4,409,016.75x
Bv Per Share	12.86
CAPEX	CNY -128.3M
Ch1m	15.05
Ch1w	2.82
Ch1y	31.51
Ch3m	20.36
Ch3y	51.87
Ch6m	28.38
Change	-0.02%
Change From Open	0.77
Close	40.45
Days Gap	-0.79
Depreciation Amortization	47,866,701
Dollar Volume	128,070,608.8
Earnings Date	2026-04-16
EBIT	CNY 36M
EBITDA	CNY 83.8M
EPS	CNY 0.21
F Score	5
FCF	CNY -53.1M
FCF EV Yield	-1.27x
FCF Per Share	CNY -0.49
Financing CF	69,536,039
Fiscal Year End	December
Founded	2,004
Goodwill	1,025,455
Graham Number	7.85543
Graham Upside	-80.58
Income Tax	CNY 2M
Investing CF	129,879,934
Is Primary Listing	1
Last Earnings Date	2026-04-16
Last Report Date	2026-03-31
Last Split Date	2023-05-26
Last Split Type	Forward
Lynch Fair Value	CNY 1.07
Lynch Upside	-97.36
Ma150	34.5
Ma150ch	17.22%
Ma20	38.09
Ma20ch	6.18%
Net CF	274,393,023
Next Earnings Date	2026-08-14
Open	40.13
P OCF Ratio	58.28
Payment Date	2025-05-20
Position In Range	54.55
Ppne	683,331,483
Price Date	2026-05-08
Price EBITDA	CNY 52.24
Ptbv Ratio	3.43
Relative Volume	0.72x
Revenue	448,326,039x
Tax By Revenue	0.44x
Tax Rate	7.66%
Tr6m	28.38%
Volume	3,166,929

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301281 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.05 annual per share

Payout ratio

+110.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-2.1%

Next ex-dividend date: 2025-05-20

Performance

SHE/301281 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301281?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.2%

Share of float held by funds and institutions

Insider ownership

+4.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.2%

Negative means the company is buying back shares.

Technical

SHE/301281 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.4

Neutral momentum band

Price vs 200-day MA

+16.3%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301281

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301281 stock rating?

she/301281 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301281 analysis?

The full report lives at /stocks/she/301281/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301281?

The latest report frames she/301281 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301281 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.